NCT03311542 2018-01-10Expanded Access for Pembrolizumab (MK-3475)Center Trials & TreatmentNo longer available
NCT01005537 2010-08-06Cyclophosphamide, Autologous Lymphocytes, and Aldesleukin in Treating Patients With Metastatic MelanomaFred Hutchinson Cancer CenterNo longer available